Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FREEDOM DR: An International, Multi-Center, 12-Week, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study Followed by a 12-Week Open-Label Extension Study to Assess the Efficacy, Safety, and Dose Response of UT-15C SR in Subjects With Pulmonary Hypertension

NCT00760916 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.

NCT NCT00760916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00760916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FREEDOM DR: An International, Multi-Center, 12-Week, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study Followed by a 12-Week Open-Label Extension Study to Assess the Efficacy, Safety, and Dose Response of UT-15C SR in Subjects With Pulmonary Hypertension
Lead sponsor
United Therapeutics
Phase
Phase 3
Overall status
Withdrawn
Start date
December 31, 2008
Completion date
January 31, 2009
Enrollment
0 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension